Showing results (161-170 of 332) with videos related to
Sort By:
Pageof 34
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchangeC V Harding, R W Roof, E R UnanueAmerican Journal of Epidemiology|January 24, 1998
Risk factors for nuclear opalescence in a longitudinal study. LSC Group. Longitudinal Study of CataractM C Leske, L T Chylack, Q He, et al.Experimental Eye Research|February 1, 1985
Sorbitol/fructose metabolism in the lensH M Cheng, R G González, P A Barnett, et al.Ophthalmology|May 1, 1996
Incidence and progression of nuclear opacities in the Longitudinal Study of CataractM C Leske, L T Chylack, S Y Wu, et al.Ophthalmology|May 21, 1998
Antioxidant vitamins and nuclear opacities: the longitudinal study of cataractM C Leske, L T Chylack, Q He, et al.Ophthalmology|December 24, 1997
Incidence and progression of cortical and posterior subcapsular opacities: the Longitudinal Study of Cataract. The LSC GroupM C Leske, L T Chylack, Q He, et al.Cellular Microbiology|February 24, 2001
Phagocytic processing of antigens for presentation by class II major histocompatibility complex moleculesL Ramachandra, E Noss, W H Boom, et al.The Journal of Experimental Medicine|November 21, 2001
Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturationL Ramachandra, E Noss, W H Boom, et al.Journal of Cataract and Refractive Surgery|May 1, 1993
Contrast sensitivity and visual acuity in patients with early cataractsL T Chylack, G Jakubicz, B Rosner, et al.Cancer Research|August 29, 1998
Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell linesA Johnsen, J France, M S Sy, et al.Pageof 34